High materiality7/10
Chemours (CC) PT Lowered to $16 at Goldman Sachs
Why it may matterVerify against the original reporting
Upside remains despite downgrade; target above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CC received an analyst target update from Goldman Sachs.
- Target: $16; Posted price: $13.89; Firm: Goldman Sachs
Key facts
- 01
Target: $16
- 02
Posted price: $13.89
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Duffy Fischer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.